Modulation of cell surface antigens accompanies morphological differentiation of human neuroblastoma cell lines.
Reynolds
C P
CP
Maples
J
J
D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis*; D001369:Axons / Q000276:immunology / Q000473:pathology; D001973:Bromodeoxyuridine / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D006801:Humans; D009447:Neuroblastoma / Q000276:immunology* / Q000473:pathology; D009457:Neuroglia / Q000276:immunology / Q000473:pathology; D009474:Neurons / Q000276:immunology / Q000473:pathology; D012583:Schwann Cells / Q000276:immunology / Q000473:pathology; D014212:Tretinoin / Q000494:pharmacology
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D014212:Tretinoin; D003994:Bucladesine; D001973:Bromodeoxyuridine